bupropion has been researched along with glutamic acid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, L; Yang, CR | 1 |
Grillner, S; Hill, RH; Svensson, E; Wikström, MA | 1 |
Chang, B; Fagen, ZM; Mansvelder, HD; McGehee, DS; Mitchum, R | 1 |
Arias, HR; SantamarĂa, A | 1 |
Lin, TY; Lu, CW; Wang, SJ; Yang, TT | 1 |
Barakat, A; Elbadr, MM; Hamdy, MM | 1 |
7 other study(ies) available for bupropion and glutamic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex.
Topics: Action Potentials; Animals; Benzazepines; Bupropion; Clozapine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Electric Stimulation; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; Male; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate | 2002 |
Endogenous and exogenous dopamine presynaptically inhibits glutamatergic reticulospinal transmission via an action of D2-receptors on N-type Ca2+ channels.
Topics: Animals; Axons; Bupropion; Calcium Channel Blockers; Calcium Channels, N-Type; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Lampreys; Membrane Potentials; omega-Conotoxin GVIA; Patch-Clamp Techniques; Receptors, Dopamine D2; Receptors, Presynaptic; Reticular Formation; Salicylamides; Spinal Cord; Synaptic Transmission | 2003 |
Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area.
Topics: Action Potentials; Animals; Bupropion; gamma-Aminobutyric Acid; Glutamic Acid; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Ventral Tegmental Area | 2007 |
Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Appetite Depressants; Behavior, Animal; Bupropion; Diethylpropion; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamic Acid; Male; Microdialysis; Neostriatum; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Wistar; Synaptic Transmission | 2010 |
Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals.
Topics: Amino Acid Transport System X-AG; Animals; Antidepressive Agents, Second-Generation; Bupropion; Calcium; Calcium Channels; Cerebral Cortex; Glutamic Acid; Male; Membrane Potentials; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nerve Endings; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Synaptosomes | 2011 |
Bupropion attenuates morphine tolerance and dependence: Possible role of glutamate, norepinephrine, inflammation, and oxidative stress.
Topics: Animals; Brain; Bupropion; Dose-Response Relationship, Drug; Drug Tolerance; Glutamic Acid; Glutathione; Inflammation; Male; Malondialdehyde; Mice; Morphine; Morphine Dependence; Naloxone; Nitric Oxide; Norepinephrine; Organophosphorus Compounds; Oxidative Stress; Pain Measurement; Substance Withdrawal Syndrome | 2018 |